Merck - Vioxx Controversy

Vioxx Controversy Romain Floyd, Suki Fuller, Andrea Villanera, Michele Barone, Steven Smith

Merck ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Major Players ,[object Object],[object Object],[object Object],[object Object]

Reputation ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Competition to Vioxx® ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

What is Vioxx ® ? ,[object Object],[object Object],[object Object]

Description ,[object Object],[object Object],[object Object],[object Object]

Clinical Studies of Vioxx® ,[object Object],[object Object]

Vioxx® Indications and Usage ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Vioxx® advantage ,[object Object],[object Object],[object Object],[object Object],[object Object]

Contraindications ,[object Object],[object Object],[object Object]

Warnings ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Sales Incentives ,[object Object],[object Object],[object Object],[object Object],[object Object]

Marketing Vioxx® ,[object Object],[object Object],[object Object]

Vioxx® Dangers ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Vioxx® and Merck ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Vioxx and Industry ,[object Object],[object Object],[object Object],[object Object]

Industry Analysis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Industry Analysis (continued) ,[object Object]

Vioxx® Evaluation ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Pulling Vioxx From the Market ,[object Object],[object Object],[object Object]

Merck Analysis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Merck Analysis (continued) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Future Outlook ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Recent Headlines ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Closing Statement / Questions Questions?

Sources ,[object Object],[object Object],[object Object],[object Object],[object Object]

Sources ,[object Object],[object Object],[object Object],[object Object]

Sources ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Merck - Vioxx Controversy

Empfohlen

Empfohlen

Weitere ähnliche Inhalte

Was ist angesagt?

Was ist angesagt? (20)

Andere mochten auch

Andere mochten auch (16)

Ähnlich wie Merck - Vioxx Controversy

Ähnlich wie Merck - Vioxx Controversy (20)

Kürzlich hochgeladen

Kürzlich hochgeladen (20)

Merck - Vioxx Controversy